Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: liver cirrhosis + liver + cirrhosis  Related to the article below (Last Update: 8/5/2008)


Javno.hr
From Pub Euphoria to Liver Cirrhosis or Prison
Javno.hr, Croatia - 39 minutes ago
The reduced capability of thinking rationally leads to apathy, while lingeringly abuse of alcohol leads to alcoholic psychoses. Although in many cases we ...
DOES IT WORK: D?nal ? Math?na looks at Milk thistle as a ...
Irish Times, Ireland -
Alcohol is the most common cause of liver damage. More commonly, the extract is used to treat jaundice, cirrhosis of the liver (especially related to ...
Liver disease brings couple closer in many ways
Arizona Republic, AZ - Aug 2, 2008
She contracted primary sclerosing cholangitis, an incurable disease of unknown origin that ultimately leads to cirrhosis of the liver and liver failure, ...
Penn researchers find a new role for a 'Foxy Old Gene'
Hindu, India - Aug 3, 2008
PSC is associated with an increased risk of liver cirrhosis and liver cancer. Biliary atresia is a birth defect in which the bile ducts do not have normal ...
Liver Damage In Hepatitis C Patients Could Be Treated With ...
Science Daily (press release) - Aug 1, 2008
... on the liver caused by Hepatitis C. This scarring, or fibrosis, replaces normal liver cells and can lead to cirrhosis of the liver and ultimately liver ...
Tracleer? (bosentan) receives EU approval for treatment of ...
Ad-Hoc-News (Pressemitteilung), Germany - Aug 3, 2008
... Potential for serious liver injury (including rare cases of liver failure and unexplained hepatic cirrhosis in a setting of close monitoring) - Liver ...VTX:ATLN
Mettle beyond medals
News-Herald.com, OH -
Nancy was 18 when she was diagnosed with cryptogenic cirrhosis of the liver. Her condition worsened over the years to the point where she could only sit ...
Top-Line Results of Boceprevir Phase II Study Showed High Rate of ...
CNNMoney.com (press release) -
It is the leading cause of cirrhosis and liver cancer, and the number one reason for liver transplants in the United States and Europe. ...SGP
Sucampo Initiates Enrollment for Phase II Liver Cirrhosis Trial
RedOrbit, TX - Jul 29, 2008
Secondary endpoints include acute changes in HVPG following initial dosing with cobiprostone, as well as changes in other markers of liver disease and ...SCMP
Pasig hospital offers fresh hope to liver cancer patients
Inquirer.net, Philippines - Aug 1, 2008
Hepa B, he said, usually developed into cirrhosis or cancer of the liver. He added that Filipinos would save a lot of money having the procedure done here ...
Source: Google News

Hepatocyte growth factor gene therapy of liver cirrhosis in rats -
T Ueki, Y Kaneda, H Tsutsui, K Nakanishi, Y Sawa, … - Nature Medicine, 1999 - nature.com
... Hepatocyte growth factor gene therapy of liver cirrhosis in rats. ... Thus, HGF gene
therapy may have improved the liver cirrhosis by inhibiting TGF- expression. ...

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. -
G Mazzella, E Accogli, S Sottili, D Festi, M … - J Hepatol, 1996 - ncbi.nlm.nih.gov
J Hepatol. 1996 Feb;24(2):141-7. Click here to read Alpha interferon treatment may
prevent hepatocellular carcinoma in HCV-related liver cirrhosis. ...

Experimental liver cirrhosis induced by alcohol and iron. -
H Tsukamoto, W Horne, S Kamimura, O Niemel?, S … - Journal of Clinical Investigation, 1995 - pubmedcentral.nih.gov
... Clin Invest. 1995 July; 96(1): 620?630. Copyright notice. Experimental
liver cirrhosis induced by alcohol and iron. H Tsukamoto ...

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, …
T Poynard, P Bedossa, P Opolon - Lancet, 1997 - ncbi.nlm.nih.gov
... on a five-point scale, F0 = no fibrosis, F4 = cirrhosis, and histological ... No patient
had received interferon treatment before the liver biopsy sample was ...

… Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis -
V Mazzaferro, E Regalia, R Doci, S Andreola, A … - New England Journal of Medicine, 1996 - content.nejm.org
... 2004). Ultrasound guided fine needle biopsy of early hepatocellular carcinoma
complicating liver cirrhosis: a multicentre study. Gut ...

… to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. -
J Bruix, JM Barrera, X Calvet, G Ercilla, J Costa, … - Lancet, 1989 - ncbi.nlm.nih.gov
... of antibodies against hepatitis C virus (HCV) was investigated in 96 patients with
hepatocellular carcinoma, 106 patients with liver cirrhosis without evidence ...

Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, … -
NN Zein, AS Abdulkarim, RH Wiesner, KS Egan, DH … - J Hepatol, 2000 - ncbi.nlm.nih.gov
Click here to read Prevalence of diabetes mellitus in patients with end-stage liver
cirrhosis due to hepatitis C, alcohol, or cholestatic disease. ...

Noninvasive diagnosis of liver cirrhosis using DNA sequencer?based total serum protein glycomics -
N Callewaert, HV Vlierberghe, AV Hecke, W Laroy, J … - Nature Medicine, 2004 - palgrave-journals.com
... 10.1038/nm1006 Noninvasive diagnosis of liver cirrhosis using DNA
sequencer-based total serum protein glycomics. Nico Callewaert ...

… -like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis -
E Cariani - Cancer Research, 1988 - AACR
... ARTICLES. Differential expression of insulin-like growth factor II mRNA in human
primary liver cancers, benign liver tumors, and liver cirrhosis. ...

Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery -
KL Rudolph, S Chang, M Millard, N Schreiber-Agus, … - Science, 2000 - sciencemag.org
... Reports. Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery. ...
6. Reactivation of telomerase reduces liver cirrhosis in G6 mTR / mice. ...

Source: Google Scholar
 

Cirrhosis of the Liver

The liver, the largest organ in the body, is essential in keeping the body functioning properly. It removes or neutralizes poisons from the blood, produces immune agents to control infection, and removes germs and bacteria from the blood. It makes proteins that regulate blood clotting and produces bile to help absorb fats and fat-soluble vitamins. You cannot live without a functioning liver.

In cirrhosis of the liver, scar tissue replaces normal, healthy tissue, blocking the flow of blood through the organ and preventing it from working as it should. Cirrhosis is the twelfth leading cause of death by disease, killing about 26,000 people each year. Also, the cost of cirrhosis in terms of human suffering, hospital costs, and lost productivity is high.

Article continues below and (thank you)

 

Causes

Cirrhosis has many causes. In the United States, chronic alcoholism and hepatitis C are the most common ones.

Alcoholic liver disease. To many people, cirrhosis of the liver is synonymous with chronic alcoholism, but in fact, alcoholism is only one of the causes. Alcoholic cirrhosis usually develops after more than a decade of heavy drinking. The amount of alcohol that can injure the liver varies greatly from person to person. In women, as few as two to three drinks per day have been linked with cirrhosis and in men, as few as three to four drinks per day. Alcohol seems to injure the liver by blocking the normal metabolism of protein, fats, and carbohydrates.

Chronic hepatitis C. The hepatitis C virus ranks with alcohol as a major cause of chronic liver disease and cirrhosis in the United States. Infection with this virus causes inflammation of and low grade damage to the liver that over several decades can lead to cirrhosis.

Chronic hepatitis B and D. The hepatitis B virus is probably the most common cause of cirrhosis worldwide, but it is less common in the United States and the Western world. Hepatitis B, like hepatitis C, causes liver inflammation and injury that over several decades can lead to cirrhosis. Hepatitis D is another virus that infects the liver, but only in people who already have hepatitis B.

Autoimmune hepatitis. This disease appears to be caused by the immune system attacking the liver and causing inflammation, damage, and eventually scarring and cirrhosis.

Inherited diseases. Alpha-1 antitrypsin deficiency, hemochromatosis, Wilson's disease, galactosemia, and glycogen storage diseases are among the inherited diseases that interfere with the way the liver produces, processes, and stores enzymes, proteins, metals, and other substances the body needs to function properly.

Nonalcoholic steatohepatitis (NASH). In NASH, fat builds up in the liver and eventually causes scar tissue. This type of hepatitis appears to be associated with diabetes, protein malnutrition, obesity, coronary artery disease, and treatment with corticosteroid medications.

Blocked bile ducts. When the ducts that carry bile out of the liver are blocked, bile backs up and damages liver tissue. In babies, blocked bile ducts are most commonly caused by biliary atresia, a disease in which the bile ducts are absent or injured. In adults, the most common cause is primary biliary cirrhosis, a disease in which the ducts become inflamed, blocked, and scarred. Secondary biliary cirrhosis can happen after gallbladder surgery if the ducts are inadvertently tied off or injured.

Drugs, toxins, and infections. Severe reactions to prescription drugs, prolonged exposure to environmental toxins, the parasitic infection schistosomiasis, and repeated bouts of heart failure with liver congestion can all lead to cirrhosis.

 

Symptoms

Many people with cirrhosis have no symptoms in the early stages of the disease. However, as scar tissue replaces healthy cells, liver function starts to fail and a person may experience the following symptoms:

  • exhaustion

  • fatigue

  • loss of appetite

  • nausea

  • weakness

  • weight loss

  • abdominal pain

  • spider-like blood vessels (spider angiomas) that develop on the skin

As the disease progresses, complications may develop. In some people, these may be the first signs of the disease.

 

Complications of Cirrhosis

Loss of liver function affects the body in many ways. Following are the common problems, or complications, caused by cirrhosis.

Edema and ascites. When the liver loses its ability to make the protein albumin, water accumulates in the legs (edema) and abdomen (ascites).

Bruising and bleeding. When the liver slows or stops production of the proteins needed for blood clotting, a person will bruise or bleed easily. The palms of the hands may be reddish and blotchy with palmar erythema.

Jaundice. Jaundice is a yellowing of the skin and eyes that occurs when the diseased liver does not absorb enough bilirubin.

Itching. Bile products deposited in the skin may cause intense itching.

Gallstones. If cirrhosis prevents bile from reaching the gallbladder, gallstones may develop.

Toxins in the blood or brain. A damaged liver cannot remove toxins from the blood, causing them to accumulate in the blood and eventually the brain. There, toxins can dull mental functioning and cause personality changes, coma, and even death. Signs of the buildup of toxins in the brain include neglect of personal appearance, unresponsiveness, forgetfulness, trouble concentrating, or changes in sleep habits.

Sensitivity to medication. Cirrhosis slows the liver's ability to filter medications from the blood. Because the liver does not remove drugs from the blood at the usual rate, they act longer than expected and build up in the body. This causes a person to be more sensitive to medications and their side effects.

Portal hypertension. Normally, blood from the intestines and spleen is carried to the liver through the portal vein. But cirrhosis slows the normal flow of blood through the portal vein, which increases the pressure inside it. This condition is called portal hypertension.

Varices. When blood flow through the portal vein slows, blood from the intestines and spleen backs up into blood vessels in the stomach and esophagus. These blood vessels may become enlarged because they are not meant to carry this much blood. The enlarged blood vessels, called varices, have thin walls and carry high pressure, and thus are more likely to burst. If they do burst, the result is a serious bleeding problem in the upper stomach or esophagus that requires immediate medical attention.

Insulin resistance and type 2 diabetes. Cirrhosis causes resistance to insulin. This hormone, produced by the pancreas, enables blood glucose to be used as energy by the cells of the body. If you have insulin resistance, your muscle, fat, and liver cells do not use insulin properly. The pancreas tries to keep up with the demand for insulin by producing more. Eventually, the pancreas cannot keep up with the body's need for insulin, and type 2 diabetes develops as excess glucose builds up in the bloodstream.

Liver cancer. Hepatocellular carcinoma, a type of liver cancer commonly caused by cirrhosis, starts in the liver tissue itself. It has a high mortality rate.

Problems in other organs. Cirrhosis can cause immune system dysfunction, leading to infection. Fluid in the abdomen (ascites) may become infected with bacteria normally present in the intestines. Cirrhosis can also lead to impotence, kidney dysfunction and failure, and osteoporosis.

 

Diagnosis

The doctor may diagnose cirrhosis on the basis of symptoms, laboratory tests, the medical history, and a physical examination. For example, during a physical examination, the doctor may notice that the liver feels harder or larger than usual and order blood tests that can show whether liver disease is present.

If looking at the liver is necessary to check for signs of disease, the doctor might order a computerized axial tomography (CAT) scan, ultrasound, magnetic resonance imaging (MRI), or a scan of the liver using a radioisotope (a harmless radioactive substance that highlights the liver). Or the doctor might look at the liver using a laparoscope, an instrument that is inserted through the abdomen and relays pictures back to a computer screen.

A liver biopsy will confirm the diagnosis. For a biopsy, the doctor uses a needle to take a tiny sample of liver tissue, then examines it under the microscope for scarring or other signs of disease.

 

Treatment

Liver damage from cirrhosis cannot be reversed, but treatment can stop or delay further progression and reduce complications. Treatment depends on the cause of cirrhosis and any complications a person is experiencing. For example, cirrhosis caused by alcohol abuse is treated by abstaining from alcohol. Treatment for hepatitis-related cirrhosis involves medications used to treat the different types of hepatitis, such as interferon for viral hepatitis and corticosteroids for autoimmune hepatitis. Cirrhosis caused by Wilson's disease, in which copper builds up in organs, is treated with medications to remove the copper. These are just a few examples—treatment for cirrhosis resulting from other diseases depends on the underlying cause. In all cases, regardless of the cause, following a healthy diet and avoiding alcohol are essential because the body needs all the nutrients it can get, and alcohol will only lead to more liver damage. Light physical activity can help stop or delay cirrhosis as well.

Treatment will also include remedies for complications. For example, for ascites and edema, the doctor may recommend a low-sodium diet or the use of diuretics, which are drugs that remove fluid from the body. Antibiotics will be prescribed for infections, and various medications can help with itching. Protein causes toxins to form in the digestive tract, so eating less protein will help decrease the buildup of toxins in the blood and brain. The doctor may also prescribe laxatives to help absorb the toxins and remove them from the intestines.

For portal hypertension, the doctor may prescribe a blood pressure medication such as a beta-blocker. If varices bleed, the doctor may either inject them with a clotting agent or perform a so-called rubber-band ligation, which uses a special device to compress the varices and stop the bleeding.

When complications cannot be controlled or when the liver becomes so damaged from scarring that it completely stops functioning, a liver transplant is necessary. In liver transplantation surgery, a diseased liver is removed and replaced with a healthy one from an organ donor. About 80 to 90 percent of patients survive liver transplantation. Survival rates have improved over the past several years because of drugs such as cyclosporine and tacrolimus, which suppress the immune system and keep it from attacking and damaging the new liver.

 

For More Information

American Liver Foundation (ALF)
75 Maiden Lane, Suite 603
New York, NY 10038–4810
Phone: 1–800–GO–LIVER (465–4837),
1–888–4HEP–USA (443–7872),
or 212–668–1000
Fax: 212–483–8179
Email: info@liverfoundation.org
Internet: www.liverfoundation.org

Hepatitis Foundation International
504 Blick Drive
Silver Spring, MD 20904–2901
Phone: 1–800–891–0707 or 301–622–4200
Fax: 301–622–4702
Email: hfi@comcast.net
Internet: www.hepfi.org

United Network for Organ Sharing
P.O. Box 2484
Richmond, VA 23218
Phone: 1–888–894–6361 or 804–782–4800
Internet: www.unos.org

National Digestive Diseases Information Clearinghouse

2 Information Way
Bethesda, MD 20892–3570
Email: nddic@info.niddk.nih.gov

The National Digestive Diseases Information Clearinghouse (NDDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health of the U.S. Department of Health and Human Services. Established in 1980, the Clearinghouse provides information about digestive diseases to people with digestive disorders and to their families, health care professionals, and the public. The NDDIC answers inquiries, develops and distributes publications, and works closely with professional and patient organizations and Government agencies to coordinate resources about digestive diseases.

Publications produced by the Clearinghouse are carefully reviewed by both NIDDK scientists and outside experts.

This publication is not copyrighted. The Clearinghouse encourages users of this publication to duplicate and distribute as many copies as desired.


NIH Publication No. 04–1134
December 2003

 
 
 
Google
Web www.iconocast.com
 
 
Continue News With: News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast